Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
Status:
Unknown status
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacological efficacy on language capability and compliance
with combination of new Ebixa oral pump and donepezil compared to donepezil only in patients
with probable Alzheimer's disease. Primary objective is to evaluate the efficacy of memantine
on language capability in moderate to severe Alzheimer's disease patients who are taking
stable donepezil treatment.Secondary objectives are to evaluate the efficacy of maintain on
cognitive function and disease progression with K-MMSE, NPI, ROSA, and SIB-short form in
probable AD.